19:38:27 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-03-07 Kvartalsrapport 2024-Q2
2023-11-17 Ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 Årsstämma 2024
2023-09-28 Bokslutskommuniké 2023
2023-04-24 Extra Bolagsstämma 2023
2023-03-23 Kvartalsrapport 2023-Q2
2022-11-17 Årsstämma 2023
2022-10-25 Ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 Bokslutskommuniké 2022
2022-06-29 Extra Bolagsstämma 2022
2022-02-24 Kvartalsrapport 2022-Q2
2021-10-29 Ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 Årsstämma 2022
2021-09-15 Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa.
2021-03-30 08:30:00

Nightingale Health Plc - Managers' transactions - 30 March 2021 9:30 a.m. (Finnish time)

Nightingale Health Plc - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Soininen, Timo

Position: Member of the Board/Deputy member

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 743700WUIPC24LVMLO66_20210330085027_2

____________________________________________

Transaction date: 2021-03-29

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 500 Unit price: 5.18 EUR

(2): Volume: 500 Unit price: 5.18 EUR

(3): Volume: 460 Unit price: 5.18 EUR

(4): Volume: 355 Unit price: 5.18 EUR

(5): Volume: 385 Unit price: 5.18 EUR

(6): Volume: 615 Unit price: 5.18 EUR

(7): Volume: 924 Unit price: 5.18 EUR

(8): Volume: 133 Unit price: 5.16 EUR

(9): Volume: 653 Unit price: 5.18 EUR

(10): Volume: 203 Unit price: 5.18 EUR

(11): Volume: 323 Unit price: 5.18 EUR

(12): Volume: 1,474 Unit price: 5.18 EUR

(13): Volume: 130 Unit price: 5.12 EUR

(14): Volume: 228 Unit price: 5.1 EUR

(15): Volume: 273 Unit price: 5.16 EUR

(16): Volume: 582 Unit price: 5.16 EUR

(17): Volume: 710 Unit price: 5.16 EUR

(18): Volume: 1,000 Unit price: 5.16 EUR

(19): Volume: 239 Unit price: 5.14 EUR

(20): Volume: 30 Unit price: 5.1 EUR

(21): Volume: 163 Unit price: 5.04 EUR

(22): Volume: 120 Unit price: 5.1 EUR

Aggregated transactions

(22): Volume: 10,000 Volume weighted average price: 5.16756 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com,tel. +358 20 730 1810

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.